JP2024537170A5 - - Google Patents
Info
- Publication number
- JP2024537170A5 JP2024537170A5 JP2024520862A JP2024520862A JP2024537170A5 JP 2024537170 A5 JP2024537170 A5 JP 2024537170A5 JP 2024520862 A JP2024520862 A JP 2024520862A JP 2024520862 A JP2024520862 A JP 2024520862A JP 2024537170 A5 JP2024537170 A5 JP 2024537170A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- nucleic acid
- amino acid
- encoded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163252850P | 2021-10-06 | 2021-10-06 | |
| US63/252,850 | 2021-10-06 | ||
| PCT/US2022/077610 WO2023060126A1 (en) | 2021-10-06 | 2022-10-05 | Engineered cytokine receptors for tunable adoptive cell therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024537170A JP2024537170A (ja) | 2024-10-10 |
| JP2024537170A5 true JP2024537170A5 (cg-RX-API-DMAC7.html) | 2026-05-20 |
Family
ID=85803736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024520862A Pending JP2024537170A (ja) | 2021-10-06 | 2022-10-05 | 調整可能な養子細胞療法のための操作されたサイトカイン受容体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240408139A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4413029A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024537170A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022361486A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3233987A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023060126A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4630446A1 (en) * | 2022-12-06 | 2025-10-15 | Dynamic Cell Therapies, Inc. | Engineered switches for immune cell activity and methods of use thereof |
| EP4630043A1 (en) * | 2022-12-06 | 2025-10-15 | Dynamic Cell Therapies, Inc. | Immune-activating complexes |
| WO2025039159A1 (en) * | 2023-08-21 | 2025-02-27 | Hangzhou Hervor Therapeutics Co., Ltd | Synthetic cytokine signaling system, preparation method, and uses thereof |
| WO2025255267A1 (en) * | 2024-06-05 | 2025-12-11 | Dynamic Cell Therapies, Inc. | Engineered receptors for activation of regulatory t-cells |
| WO2026082710A1 (en) * | 2024-10-16 | 2026-04-23 | F. Hoffmann-La Roche Ag | Small molecule-inducible recombinant receptors |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013151664A1 (en) * | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins |
| US11248058B2 (en) * | 2015-02-19 | 2022-02-15 | University Of Florida Research Foundation, Inc. | Chimeric antigen receptors and uses thereof |
| AU2016251687C1 (en) * | 2015-04-22 | 2023-07-27 | CureVac SE | RNA containing composition for treatment of tumor diseases |
| GB201507368D0 (en) * | 2015-04-30 | 2015-06-17 | Ucl Business Plc | Cell |
| CN113307864A (zh) * | 2015-06-12 | 2021-08-27 | 艾希奥美公司 | 用于产生嵌合多肽的方法和组合物 |
| CN108697798A (zh) * | 2016-02-16 | 2018-10-23 | 达纳-法伯癌症研究所有限公司 | 免疫疗法组合物及方法 |
| AU2019227979B2 (en) * | 2018-03-02 | 2024-09-05 | Allogene Therapeutics, Inc. | Inducible chimeric cytokine receptors |
| WO2019236522A1 (en) * | 2018-06-04 | 2019-12-12 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for targeted immunotherapy |
| SG11202100935TA (en) * | 2018-09-28 | 2021-02-25 | Massachusetts Inst Technology | Collagen-localized immunomodulatory molecules and methods thereof |
| US20200147137A1 (en) * | 2018-11-08 | 2020-05-14 | WUGEN, Inc. | Compositions and methods for treatment of cancer |
| US20230348556A1 (en) * | 2019-02-21 | 2023-11-02 | Arbele Limited | Artificial immunosurveillance chimeric antigen receptor and cells expressing the same |
| JP2022525781A (ja) * | 2019-03-20 | 2022-05-19 | マサチューセッツ インスティテュート オブ テクノロジー | 免疫細胞療法における両親媒性物質の使用およびそのための組成物 |
| EP3881866A1 (en) * | 2020-03-16 | 2021-09-22 | GEMoaB GmbH | A targeting module comprising pd-l1 and/or pd-l2 for use in a method for stimulating a chimeric antigen receptor mediated response in a mammal |
| US20230149465A1 (en) * | 2020-04-06 | 2023-05-18 | Celledit Llc | Genetically modified immune cells expressing a chimeric antigen receptor and having reduced proinflammatory cytokine signaling |
| AU2021347320A1 (en) * | 2020-09-24 | 2023-05-11 | The Jackson Laboratory | Humanized mouse models for assessing immune cell therapy |
| EP4630043A1 (en) * | 2022-12-06 | 2025-10-15 | Dynamic Cell Therapies, Inc. | Immune-activating complexes |
| EP4630446A1 (en) * | 2022-12-06 | 2025-10-15 | Dynamic Cell Therapies, Inc. | Engineered switches for immune cell activity and methods of use thereof |
-
2022
- 2022-10-05 WO PCT/US2022/077610 patent/WO2023060126A1/en not_active Ceased
- 2022-10-05 JP JP2024520862A patent/JP2024537170A/ja active Pending
- 2022-10-05 AU AU2022361486A patent/AU2022361486A1/en active Pending
- 2022-10-05 EP EP22879450.9A patent/EP4413029A4/en active Pending
- 2022-10-05 US US18/699,108 patent/US20240408139A1/en active Pending
- 2022-10-05 CA CA3233987A patent/CA3233987A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7141651B2 (en) | Multiple cytokine protein complexes | |
| JP2022502037A5 (cg-RX-API-DMAC7.html) | ||
| AU2003228057B2 (en) | Immunoconjugates for the treatment of tumours | |
| EP3749372B1 (en) | Edb targeting il-12 compositions | |
| US11987609B2 (en) | Proteinaceous heterodimer and use thereof | |
| CN114195900A (zh) | 一种抗4-1bb/pd-l1双特异性抗体及其用途 | |
| WO2015103928A1 (zh) | Il-15异源二聚体蛋白及其用途 | |
| US20070003514A1 (en) | Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination | |
| EP3843849A1 (en) | Combination therapies comprising cd137/her2 bispecific agents and pd-1 axis inhibitors and uses thereof | |
| Mohammadi et al. | Immunotherapy For Researchers | |
| JP2024546938A (ja) | マルチサブユニットサイトカインを含む二重サイトカイン融合タンパク質 | |
| JP2024544972A (ja) | Sirp1a及びcd40lベースのキメラタンパク質 | |
| CN114746106A (zh) | 通过肿瘤中使用il-7融合蛋白增加淋巴细胞数的方法 | |
| WO2024193705A1 (en) | Tnf superfamily member immunocytokine and uses thereof | |
| CN109414509B (zh) | 使用双特异性抗体的抗体药物偶联物平台 | |
| JP2025540340A (ja) | キメラ抗原受容体 | |
| WO2025217954A1 (zh) | 抗pd-1抗体与il-2突变体的双功能融合蛋白 | |
| EP1731531A2 (en) | Multiple cytokine-antibody complexes | |
| WO2021212037A1 (en) | Immune cell redirecting compositions and therapeutic uses thereof | |
| JP2023521174A (ja) | インターロイキン1受容体アクセサリータンパク質に特異的なバインダーおよびキメラ抗原受容体 | |
| CN116621966B (zh) | 治疗性核酸分子、混合物、药物及在治疗实体瘤中的应用 | |
| JP2024527963A5 (cg-RX-API-DMAC7.html) | ||
| TW202444742A (zh) | 經工程化之il—21變異體及其使用方法 | |
| WO2025201438A1 (zh) | 一种双融合蛋白及其用途 | |
| CN117229397A (zh) | 抗cd40抗体及其用途 |